2The consensus conference committee. Consensus conference on the classification of ductal carcinoma in situ [ J ]. Cancer, 1997,80:1798 - 802.
3Tavassoli FA. Pathology of breast [ M ]. 2nd ed, New York:McGraw-Hill, 1999:270,278 - 88,208 - 9.
4Douglas-Jones AG,Morgan JM,Appleton MA,et al. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast[J]. J Clin Pathol,2000,53:596 -602.
5Rabban JT, Sgroi DC. Sclerosing lesions of the breast [ J ]. Semin Diagn Pathol,2004,21 ( 1 ) :42 -7.
6Jones JL,Shaw JA,Pringle JH,et al. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells[J]. J Pathol,2003,201:562 -72.
7Rosen PP. Rosen's breast pathology[M]. 2nd ed,Philadelphia:Lippincott Willams & Wilkins,2001:6,215 -22.
8Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics, tumours of the breast and famale genital organs[ M ]. Lyon: IARC Press ,2003:74 - 5,65 - 6,63 -4.
9Simpson PT,Gale T,Reis-Filho JS,et al. Distribution and significance of 14-3-3σ, a novel myoepithelial marker, in normal, benign,and malignant breast tissue[J]. J Pathol,2004,202:274 - 85.
10Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology[J]. Am J Surg Pathol,2004 ,28(8) :1076 -91.
二级参考文献55
1[1]Nayar R, Breland C, Bedrossian U,et al. Immunoreactivity of ductal cells with putative myoepithelial markers: A potential pitfall in breast carcinoma. Ann Diagn Pathol, 1999,3(3): 165～73.
2[2]Wang X, Mori I, Tang W,et al. p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer, 2002,9(3):216～9.
3[3]Werling RW, Hwang H, Yaziji H,et al. Immunohistochemical distinction of invasive from noninvasive breast lesions:A comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol, 2003,27(1):82～90.
4[4]Ribeiro-Silva A, Zamzelli Ramalho LN, Garcia SB, et al. Is p63 reliable in detecting microinvasion in ductal carcinoma in situ of the breast? Pathol Oncol Res, 2003,9(1): 20～3.
5Lazard D,Sastre X,Frid MG,et al. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue[J]. Proc Natl Acad Sci USA,1993,90:999-1003.
6Funahashi H,Koshikawa T,Ichihara S,et al. Different distributions of immunoreactive S100-α and S100-β protein expression in human breast cancer[J]. J Surg Oncol,1998,68:25-9.
7Moritani S,Kushima R,Sugihara H,et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections[J]. Mod Pathol,2002,15(4):397-405.
8Werling RW,Hwang H,Yaziji H,Gown AM.Immunohistochemical distinction of invasive from noninvasive breast lesions[J]. Am J Surg Pathol,2003,27(1):82-90.
9Barbareschi M,Pecciarini L,Cangi MG,et al. p63,a p53 homologue,is a selective nuclear marker of myoepithelial cells of the human breast[J]. Am J Surg Pathol,2001,25(8):1054-60.
10Tavassoli FA,Devilee P. World Health Organization classification of tumours. Pathology and genetics,tumours of the breast and female genital organs[M]. Lyon:IARC Press,2003:63-73.
9Marenholz I, Heizmann C W, Fritz G. S-100 proteins in mouse and man:from evolution to function and pathology ( including an update of the nomenclature) [ J ]. Biochem Biophys Res Commun,2004,322(4) :1111 - 1122.
10Heizmann C W, Fritz G, Schafer B W. S-100 proteins: structure,functions and pathology [ J ]. Front Biosci ,2002,7 : 1356 - 1368.
